Open access · CC0
via OpenAlex
Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning
Stanislav Listopad, Christophe Magnan, Le Z. Day, Aliya Asghar, Andrew Stolz, John A. Tayek, Zhang‐Xu Liu, Jon Jacobs, Timothy R.M. Morgan, Trina M. Norden‐Krichmar
PLOS Digital Health · 2024 · ▲ 10 citations
Abstract
Distinguishing between alcohol-associated hepatitis (AH) and alcohol-associated cirrhosis (AC) remains a diagnostic challenge. In this study, we used machine learning with transcriptomics and proteomics data from liver tissue and peripheral mononuclear blood cells (PBMCs) to classify patients with alcohol-associated liver disease. The conditions in the study were AH, AC, and healthy controls. We processed 98 PBMC RNAseq samples, 55 PBMC proteomic samples, 48 liver RNAseq samples, and 53 liver proteomic samples. First, we built separate classification and feature selection pipelines for transcriptomics and proteomics data. The liver tissue models were validated in independent liver tissue datasets. Next, we built integrated gene and protein expression models that allowed us to identify combined gene-protein biomarker panels. For liver tissue, we attained 90% nested-cross validation accuracy in our dataset and 82% accuracy in the independent validation dataset using transcriptomic data. We attained 100% nested-cross validation accuracy in our dataset and 61% accuracy in the independent validation dataset using proteomic data. For PBMCs, we attained 83% and 89% accuracy with transcriptomic and proteomic data, respectively. The integration of the two data types resulted in improved classification accuracy for PBMCs, but not liver tissue. We also identified the following gene-protein matches within the gene-protein biomarker panels: CLEC4M-CLC4M, GSTA1-GSTA2 for liver tissue and SELENBP1-SBP1 for PBMCs. In this study, machine learning models had high classification accuracy for both transcriptomics and proteomics data, across liver tissue and PBMCs. The integration of transcriptomics and proteomics into a multi-omics model yielded improvement in classification accuracy for the PBMC data. The set of integrated gene-protein biomarkers for PBMCs show promise toward developing a liquid biopsy for alcohol-associated liver disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pdig.0000447
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Listopad, S., Magnan, C., Day, L.Z., Asghar, A., Stolz, A., Tayek, J.A., Liu, Z., Jacobs, J., Morgan, T.R., & Norden‐Krichmar, T.M. (2024). Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning. <em>PLOS Digital Health</em>. https://doi.org/10.1371/journal.pdig.0000447
Vancouver
Listopad S, Magnan C, Day LZ, Asghar A, Stolz A, Tayek JA, et al. Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning. PLOS Digital Health. 2024. doi:10.1371/journal.pdig.0000447.
BibTeX
@article{stanislav2024Identi,
title = {Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning},
author = {Stanislav Listopad and Christophe Magnan and Le Z. Day and Aliya Asghar and Andrew Stolz and John A. Tayek and Zhang‐Xu Liu and Jon Jacobs and Timothy R.M. Morgan and Trina M. Norden‐Krichmar},
journal = {PLOS Digital Health},
year = {2024},
doi = {10.1371/journal.pdig.0000447},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2010
Open access · CC-BY
Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer
Protein & Cell 2025
Open access · CC0
A comprehensive multi-organ proteomic atlas of human aging across 50 years
Enlighten: Theses (The University of Glasgow) 2026
Preprint · CC-BY
Estimation of time since death using comparative proteomic and metabolomic approaches
Nature Communications 2026
Open access · CC-BY
Systematic comparison of affinity plasma proteomic technologies across multiple cohorts reveals generalizability of proteomic prediction
Cells 2026
Open access · CC-BY
Immune Ageing Clocks: A Methods-Oriented Review of Tasks, Modalities, Models, and Recalibration
International Journal of Molecular Sciences 2017
Open access · CC-BY